Xiaoning Shen

Title: Xiaoning Shen: Innovator in Nanobody Technology

Introduction

Xiaoning Shen is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of biotechnology, particularly in the development of nanobodies. His innovative work has the potential to impact therapeutic strategies in cancer treatment.

Latest Patents

Xiaoning Shen holds a patent for an "Anti-PD-L1 nanobody and use thereof." This patent discloses a nanobody that targets the human programmed death factor PD-L1. The nanobody effectively blocks the binding of PD-L1 to its receptor PD-1. The patent also includes the gene sequence encoding the nanobody, the corresponding expression vector, and the host cell capable of expressing the nanobody. Additionally, it reveals the sequence of a humanized PD-L1 nanobody, which maintains the ability to block PD-L1 binding while exhibiting high affinity and specificity.

Career Highlights

Xiaoning Shen is associated with Innovent Biologics (Suzhou) Co., Ltd., where he continues to advance his research in nanobody technology. His work is crucial in the ongoing efforts to develop effective cancer therapies.

Collaborations

Xiaoning collaborates with notable colleagues, including Xiaoniu Miao and Xiaolin Liu. Their combined expertise enhances the research and development efforts at Innovent Biologics.

Conclusion

Xiaoning Shen's contributions to nanobody technology exemplify the innovative spirit in biotechnology. His work not only advances scientific knowledge but also holds promise for future therapeutic applications.